Zdrowie i gospodarka · 11/09/2018
FDA Publishes Draft Guidance on Postapproval Changes to Drug Substances
The FDA has released a draft guidance for industry outlining recommendations for making changes to drug substance manufacturing processes during the postapproval period for approved pharmaceutical products.